

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | peptide hormone processing (GO:0016486) | 9.43787609 |
| 2 | * positive regulation of mast cell activation (GO:0033005) | 8.58214149 |
| 3 | * positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 8.11412499 |
| 4 | serotonin metabolic process (GO:0042428) | 8.09942930 |
| 5 | tyrosine phosphorylation of STAT protein (GO:0007260) | 7.66347325 |
| 6 | positive regulation of chemokine secretion (GO:0090197) | 7.53596557 |
| 7 | cytokine biosynthetic process (GO:0042089) | 7.41613532 |
| 8 | * positive regulation of leukocyte degranulation (GO:0043302) | 7.36467672 |
| 9 | cytokine metabolic process (GO:0042107) | 7.07705212 |
| 10 | primary amino compound metabolic process (GO:1901160) | 6.79167834 |
| 11 | thrombin receptor signaling pathway (GO:0070493) | 6.72375965 |
| 12 | immunoglobulin mediated immune response (GO:0016064) | 6.44013071 |
| 13 | * regulation of mast cell degranulation (GO:0043304) | 6.05597470 |
| 14 | neutrophil activation involved in immune response (GO:0002283) | 5.93453286 |
| 15 | mast cell degranulation (GO:0043303) | 5.79420657 |
| 16 | mast cell activation involved in immune response (GO:0002279) | 5.79420657 |
| 17 | * regulation of mast cell activation involved in immune response (GO:0033006) | 5.69476989 |
| 18 | regulation of chemokine secretion (GO:0090196) | 5.67723295 |
| 19 | regulation of megakaryocyte differentiation (GO:0045652) | 5.63428203 |
| 20 | * positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 5.47232761 |
| 21 | * positive regulation of regulated secretory pathway (GO:1903307) | 5.22010186 |
| 22 | indolalkylamine metabolic process (GO:0006586) | 5.18541749 |
| 23 | mammary gland alveolus development (GO:0060749) | 5.16729901 |
| 24 | bone remodeling (GO:0046849) | 5.15634374 |
| 25 | B cell mediated immunity (GO:0019724) | 5.14118943 |
| 26 | cytokine production involved in immune response (GO:0002367) | 5.10667069 |
| 27 | lipoxygenase pathway (GO:0019372) | 5.07828504 |
| 28 | actin nucleation (GO:0045010) | 5.05716888 |
| 29 | positive regulation of interleukin-17 production (GO:0032740) | 5.02502354 |
| 30 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 5.00682388 |
| 31 | T-helper 1 type immune response (GO:0042088) | 4.94470348 |
| 32 | mast cell activation (GO:0045576) | 4.94192552 |
| 33 | * regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 4.91816163 |
| 34 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.91800104 |
| 35 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.74759513 |
| 36 | definitive hemopoiesis (GO:0060216) | 4.68645739 |
| 37 | * regulation of myeloid leukocyte mediated immunity (GO:0002886) | 4.64802918 |
| 38 | * regulation of mast cell activation (GO:0033003) | 4.63696327 |
| 39 | sleep (GO:0030431) | 4.57900924 |
| 40 | * leukotriene biosynthetic process (GO:0019370) | 4.46999928 |
| 41 | * regulation of leukocyte degranulation (GO:0043300) | 4.44895272 |
| 42 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 4.38503054 |
| 43 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.30234692 |
| 44 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.26958241 |
| 45 | ATP synthesis coupled proton transport (GO:0015986) | 4.26958241 |
| 46 | germ cell migration (GO:0008354) | 4.26903437 |
| 47 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.25833917 |
| 48 | heparin metabolic process (GO:0030202) | 4.21359584 |
| 49 | heparin biosynthetic process (GO:0030210) | 4.21359584 |
| 50 | microglial cell activation (GO:0001774) | 4.18788135 |
| 51 | positive regulation of macrophage differentiation (GO:0045651) | 4.16481195 |
| 52 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.15965027 |
| 53 | cellular biogenic amine biosynthetic process (GO:0042401) | 4.12211234 |
| 54 | amine biosynthetic process (GO:0009309) | 4.12211234 |
| 55 | one-carbon compound transport (GO:0019755) | 4.10131529 |
| 56 | megakaryocyte development (GO:0035855) | 4.03754518 |
| 57 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 4.03682567 |
| 58 | cellular response to glucose stimulus (GO:0071333) | 3.96450343 |
| 59 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.91473281 |
| 60 | endothelium development (GO:0003158) | 3.81325937 |
| 61 | phagocytosis, engulfment (GO:0006911) | 3.80354586 |
| 62 | regulation of macrophage differentiation (GO:0045649) | 3.79596091 |
| 63 | * regulation of regulated secretory pathway (GO:1903305) | 3.79103551 |
| 64 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.78441473 |
| 65 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.74587395 |
| 66 | response to peptidoglycan (GO:0032494) | 3.72346033 |
| 67 | cellular response to hexose stimulus (GO:0071331) | 3.71609537 |
| 68 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.71421042 |
| 69 | negative regulation of meiosis (GO:0045835) | 3.60800100 |
| 70 | cellular response to monosaccharide stimulus (GO:0071326) | 3.60590644 |
| 71 | regulation of tyrosine phosphorylation of Stat1 protein (GO:0042510) | 3.55947989 |
| 72 | indole-containing compound metabolic process (GO:0042430) | 3.52865553 |
| 73 | deoxyribose phosphate catabolic process (GO:0046386) | 3.49880638 |
| 74 | T cell costimulation (GO:0031295) | 3.48512724 |
| 75 | midbrain development (GO:0030901) | 3.47139650 |
| 76 | cellular response to interferon-gamma (GO:0071346) | 3.45834586 |
| 77 | regulation of interleukin-17 production (GO:0032660) | 3.45783746 |
| 78 | lymphocyte costimulation (GO:0031294) | 3.45409570 |
| 79 | production of molecular mediator of immune response (GO:0002440) | 3.44893752 |
| 80 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.44250097 |
| 81 | neutrophil activation (GO:0042119) | 3.40306893 |
| 82 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 3.39830633 |
| 83 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 3.39830633 |
| 84 | adenosine receptor signaling pathway (GO:0001973) | 3.34761619 |
| 85 | aromatic amino acid family metabolic process (GO:0009072) | 3.33522962 |
| 86 | myeloid cell activation involved in immune response (GO:0002275) | 3.32158741 |
| 87 | relaxation of smooth muscle (GO:0044557) | 3.31371100 |
| 88 | negative regulation of macrophage differentiation (GO:0045650) | 3.28879073 |
| 89 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.27744099 |
| 90 | actin filament capping (GO:0051693) | 3.25563019 |
| 91 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.22089936 |
| 92 | regulation of hematopoietic progenitor cell differentiation (GO:1901532) | 3.20792208 |
| 93 | cellular response to cadmium ion (GO:0071276) | 3.20758713 |
| 94 | positive regulation of interferon-gamma production (GO:0032729) | 3.17273528 |
| 95 | modulation by symbiont of host defense response (GO:0052031) | 3.14416002 |
| 96 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.14416002 |
| 97 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.14416002 |
| 98 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.14416002 |
| 99 | modulation by symbiont of host immune response (GO:0052553) | 3.14416002 |
| 100 | positive regulation by symbiont of host defense response (GO:0052509) | 3.14416002 |
| 101 | macrophage activation involved in immune response (GO:0002281) | 3.13126432 |
| 102 | detection of molecule of bacterial origin (GO:0032490) | 3.12739954 |
| 103 | cellular response to carbohydrate stimulus (GO:0071322) | 3.10238987 |
| 104 | positive regulation of erythrocyte differentiation (GO:0045648) | 3.07424056 |
| 105 | regulation of interleukin-8 secretion (GO:2000482) | 3.07180512 |
| 106 | histamine secretion (GO:0001821) | 3.06012899 |
| 107 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.04787048 |
| 108 | blood coagulation, intrinsic pathway (GO:0007597) | 3.04706157 |
| 109 | cell wall macromolecule catabolic process (GO:0016998) | 3.04466391 |
| 110 | positive regulation of macrophage activation (GO:0043032) | 3.04460182 |
| 111 | regulation of antigen processing and presentation (GO:0002577) | 3.03381328 |
| 112 | positive regulation of antigen processing and presentation (GO:0002579) | 3.03340863 |
| 113 | lysosome localization (GO:0032418) | 3.02674965 |
| 114 | ribosomal small subunit assembly (GO:0000028) | 3.02234347 |
| 115 | positive regulation of astrocyte differentiation (GO:0048711) | 3.01823909 |
| 116 | detection of external biotic stimulus (GO:0098581) | 3.01744821 |
| 117 | leukocyte degranulation (GO:0043299) | 3.01256915 |
| 118 | response to interferon-gamma (GO:0034341) | 3.00463872 |
| 119 | angiotensin maturation (GO:0002003) | 24.9344647 |
| 120 | granulocyte activation (GO:0036230) | 2.95719777 |
| 121 | response to corticosterone (GO:0051412) | 2.94967836 |
| 122 | mature B cell differentiation involved in immune response (GO:0002313) | 2.93805124 |
| 123 | membrane budding (GO:0006900) | 2.92995361 |
| 124 | lung lobe morphogenesis (GO:0060463) | 2.91544563 |
| 125 | cellular glucose homeostasis (GO:0001678) | 2.90959061 |
| 126 | detection of bacterium (GO:0016045) | 2.90949592 |
| 127 | protein neddylation (GO:0045116) | 2.89199199 |
| 128 | negative regulation of complement activation (GO:0045916) | 2.88481886 |
| 129 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.87966217 |
| 130 | signal peptide processing (GO:0006465) | 2.87095641 |
| 131 | negative regulation of bone resorption (GO:0045779) | 2.86796475 |
| 132 | deoxyribonucleotide catabolic process (GO:0009264) | 2.86709304 |
| 133 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.85918009 |
| 134 | response to host immune response (GO:0052572) | 2.85699156 |
| 135 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.85699156 |
| 136 | mating behavior (GO:0007617) | 2.84562927 |
| 137 | regulation of B cell differentiation (GO:0045577) | 2.82437484 |
| 138 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.82257366 |
| 139 | positive regulation of activated T cell proliferation (GO:0042104) | 2.80738816 |
| 140 | positive regulation of B cell differentiation (GO:0045579) | 2.80274940 |
| 141 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.80265765 |
| 142 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.78029193 |
| 143 | respiratory electron transport chain (GO:0022904) | 2.77704953 |
| 144 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.76906751 |
| 145 | * regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 2.76889826 |
| 146 | fibrinolysis (GO:0042730) | 2.76302451 |
| 147 | * positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.75754528 |
| 148 | positive regulation of T cell proliferation (GO:0042102) | 2.75705966 |
| 149 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.73337286 |
| 150 | detection of other organism (GO:0098543) | 2.72952475 |
| 151 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.72439617 |
| 152 | electron transport chain (GO:0022900) | 2.71727120 |
| 153 | * leukotriene metabolic process (GO:0006691) | 2.70281522 |
| 154 | negative regulation of phagocytosis (GO:0050765) | 2.69804831 |
| 155 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.69797388 |
| 156 | positive regulation of response to biotic stimulus (GO:0002833) | 2.69739391 |
| 157 | cell wall macromolecule metabolic process (GO:0044036) | 2.68882319 |
| 158 | peptide metabolic process (GO:0006518) | 2.68086666 |
| 159 | muscle organ morphogenesis (GO:0048644) | 2.66939315 |
| 160 | positive regulation of myeloid cell differentiation (GO:0045639) | 2.66335953 |
| 161 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.64035768 |
| 162 | cytokine secretion (GO:0050663) | 2.63959079 |
| 163 | regulation of myeloid cell apoptotic process (GO:0033032) | 2.62808730 |
| 164 | detection of biotic stimulus (GO:0009595) | 2.62763290 |
| 165 | response to follicle-stimulating hormone (GO:0032354) | 2.60973552 |
| 166 | T cell receptor signaling pathway (GO:0050852) | 2.60815545 |
| 167 | myeloid dendritic cell activation (GO:0001773) | 2.60446342 |
| 168 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.59965140 |
| 169 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.57668977 |
| 170 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.56945782 |
| 171 | cellular response to antibiotic (GO:0071236) | 2.55673642 |
| 172 | negative regulation of protein activation cascade (GO:2000258) | 2.55635324 |
| 173 | * regulation of hypersensitivity (GO:0002883) | 2.54949121 |
| 174 | progesterone metabolic process (GO:0042448) | 2.54705375 |
| 175 | negative regulation of actin filament depolymerization (GO:0030835) | 2.53394799 |
| 176 | phenol-containing compound biosynthetic process (GO:0046189) | 2.52357066 |
| 177 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 2.52033227 |
| 178 | embryonic hemopoiesis (GO:0035162) | 2.49463106 |
| 179 | histamine transport (GO:0051608) | 2.48378933 |
| 180 | platelet aggregation (GO:0070527) | 2.44168226 |
| 181 | negative regulation of meiotic cell cycle (GO:0051447) | 2.41827328 |
| 182 | positive regulation of megakaryocyte differentiation (GO:0045654) | 12.7643516 |
| 183 | production of molecular mediator involved in inflammatory response (GO:0002532) | 11.8858988 |
| 184 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 10.9543362 |
| 185 | * positive regulation of mast cell activation involved in immune response (GO:0033008) | 10.2324721 |
| 186 | * positive regulation of mast cell degranulation (GO:0043306) | 10.2324721 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.74683078 |
| 2 | SCL_19346495_ChIP-Seq_HPC-7_Human | 5.21872812 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.90386098 |
| 4 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.98701833 |
| 5 | EGR1_19032775_ChIP-ChIP_M12_Human | 3.32505658 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.28334087 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.12760548 |
| 8 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.11143001 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.99419054 |
| 10 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.74270828 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.69865573 |
| 12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.61441911 |
| 13 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.56926010 |
| 14 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.38678107 |
| 15 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.33938684 |
| 16 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.32348889 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.29626750 |
| 18 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.21810759 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.19259216 |
| 20 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.18755465 |
| 21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.13858651 |
| 22 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.12626019 |
| 23 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.11915445 |
| 24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.08704420 |
| 25 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 13.5247425 |
| 26 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.90649424 |
| 27 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.90255446 |
| 28 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.89895503 |
| 29 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.83669451 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 1.81225922 |
| 31 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.79712902 |
| 32 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.79471612 |
| 33 | GATA1_19941826_ChIP-Seq_K562_Human | 1.78205484 |
| 34 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.74445807 |
| 35 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.71227038 |
| 36 | MAF_26560356_Chip-Seq_TH1_Human | 1.70591424 |
| 37 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.66030159 |
| 38 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.65426689 |
| 39 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.65009001 |
| 40 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.64567802 |
| 41 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.62410390 |
| 42 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.62109645 |
| 43 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.61616876 |
| 44 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.60761009 |
| 45 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.60388311 |
| 46 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.57960140 |
| 47 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.56637628 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.50855543 |
| 49 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.50450528 |
| 50 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.48759477 |
| 51 | MYC_22102868_ChIP-Seq_BL_Human | 1.48729005 |
| 52 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48702469 |
| 53 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.48225933 |
| 54 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.47892930 |
| 55 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.47580394 |
| 56 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.44896730 |
| 57 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.40915803 |
| 58 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.40890998 |
| 59 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.40785079 |
| 60 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.39115164 |
| 61 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.39003766 |
| 62 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.38781336 |
| 63 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.38438871 |
| 64 | VDR_22108803_ChIP-Seq_LS180_Human | 1.38098304 |
| 65 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.36168858 |
| 66 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35693742 |
| 67 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.34822214 |
| 68 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33152986 |
| 69 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32173668 |
| 70 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.32158353 |
| 71 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.31492739 |
| 72 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.31479601 |
| 73 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.31204261 |
| 74 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.28247933 |
| 75 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.26906202 |
| 76 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.26808502 |
| 77 | UTX_26944678_Chip-Seq_JUKART_Human | 1.25937719 |
| 78 | GATA2_19941826_ChIP-Seq_K562_Human | 1.25730815 |
| 79 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.25131886 |
| 80 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.23665119 |
| 81 | MYB_26560356_Chip-Seq_TH2_Human | 1.22606821 |
| 82 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22478694 |
| 83 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.22269017 |
| 84 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.17315084 |
| 85 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.15060004 |
| 86 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.14189062 |
| 87 | AR_20517297_ChIP-Seq_VCAP_Human | 1.13517924 |
| 88 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.13509708 |
| 89 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.12905011 |
| 90 | TP53_16413492_ChIP-PET_HCT116_Human | 1.12334876 |
| 91 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.12032717 |
| 92 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.11802553 |
| 93 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.11674763 |
| 94 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.11068424 |
| 95 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.10932907 |
| 96 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.09534955 |
| 97 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.08036161 |
| 98 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.04206611 |
| 99 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03678848 |
| 100 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03003216 |
| 101 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.02815216 |
| 102 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02450309 |
| 103 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02068805 |
| 104 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.01679909 |
| 105 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.00969980 |
| 106 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00863380 |
| 107 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.00775165 |
| 108 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00670493 |
| 109 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99417909 |
| 110 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.98719503 |
| 111 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.98426512 |
| 112 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.98249306 |
| 113 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.97952475 |
| 114 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.97066935 |
| 115 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.96873319 |
| 116 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.96687306 |
| 117 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.96537727 |
| 118 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.96536986 |
| 119 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.96402647 |
| 120 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.96152545 |
| 121 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.95635994 |
| 122 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95090279 |
| 123 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.94374686 |
| 124 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93991318 |
| 125 | * ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.93178106 |
| 126 | MYB_26560356_Chip-Seq_TH1_Human | 0.92081027 |
| 127 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.91313450 |
| 128 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.91088336 |
| 129 | GATA3_26560356_Chip-Seq_TH2_Human | 0.90788369 |
| 130 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.90759855 |
| 131 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.90669149 |
| 132 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.90626092 |
| 133 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.90626092 |
| 134 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.90626092 |
| 135 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.90496481 |
| 136 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.90201307 |
| 137 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.89904804 |
| 138 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.88617578 |
| 139 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.87873062 |
| 140 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 0.86223788 |
| 141 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.85128170 |
| 142 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.84976179 |
| 143 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84968950 |
| 144 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.84418765 |
| 145 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.84373437 |
| 146 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.84341512 |
| 147 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.84199135 |
| 148 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.83889976 |
| 149 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.83767035 |
| 150 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.83246982 |
| 151 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.83243817 |
| 152 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.83184182 |
| 153 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.82866195 |
| 154 | KDM2B_26808549_Chip-Seq_K562_Human | 0.82502431 |
| 155 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.81596779 |
| 156 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.81596779 |
| 157 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 0.81266171 |
| 158 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 0.81266171 |
| 159 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80184696 |
| 160 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.79798949 |
| 161 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77958132 |
| 162 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.77115719 |
| 163 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.76695881 |
| 164 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.75762058 |
| 165 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.74627535 |
| 166 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.74226753 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002877_abnormal_melanocyte_morpholog | 5.55273547 |
| 2 | MP0001835_abnormal_antigen_presentation | 5.45729720 |
| 3 | MP0000465_gastrointestinal_hemorrhage | 5.19740681 |
| 4 | MP0008775_abnormal_heart_ventricle | 3.95597319 |
| 5 | MP0005464_abnormal_platelet_physiology | 3.59714944 |
| 6 | MP0004808_abnormal_hematopoietic_stem | 3.57401336 |
| 7 | MP0003638_abnormal_response/metabolism_ | 3.52210484 |
| 8 | MP0003436_decreased_susceptibility_to | 3.31587245 |
| 9 | MP0003566_abnormal_cell_adhesion | 3.00805873 |
| 10 | MP0003300_gastrointestinal_ulcer | 2.91349006 |
| 11 | MP0009765_abnormal_xenobiotic_induced | 2.85556899 |
| 12 | MP0001873_stomach_inflammation | 2.68137300 |
| 13 | MP0004147_increased_porphyrin_level | 2.51679008 |
| 14 | MP0003724_increased_susceptibility_to | 2.51529225 |
| 15 | MP0003303_peritoneal_inflammation | 2.49652522 |
| 16 | MP0009785_altered_susceptibility_to | 2.31479254 |
| 17 | MP0005025_abnormal_response_to | 2.21032940 |
| 18 | MP0005387_immune_system_phenotype | 2.17007212 |
| 19 | MP0001790_abnormal_immune_system | 2.17007212 |
| 20 | MP0010329_abnormal_lipoprotein_level | 2.16675762 |
| 21 | MP0005000_abnormal_immune_tolerance | 2.07249888 |
| 22 | * MP0002420_abnormal_adaptive_immunity | 2.03261750 |
| 23 | * MP0001819_abnormal_immune_cell | 2.02362291 |
| 24 | * MP0002398_abnormal_bone_marrow | 1.95459897 |
| 25 | MP0006082_CNS_inflammation | 1.92559969 |
| 26 | * MP0002148_abnormal_hypersensitivity_rea | 1.88458775 |
| 27 | MP0005646_abnormal_pituitary_gland | 1.88353149 |
| 28 | MP0008873_increased_physiological_sensi | 1.87059120 |
| 29 | MP0006036_abnormal_mitochondrial_physio | 1.82255049 |
| 30 | MP0002166_altered_tumor_susceptibility | 1.81598194 |
| 31 | MP0004885_abnormal_endolymph | 1.75120988 |
| 32 | * MP0002419_abnormal_innate_immunity | 1.74221928 |
| 33 | MP0005174_abnormal_tail_pigmentation | 1.69329890 |
| 34 | MP0000516_abnormal_urinary_system | 1.68668520 |
| 35 | MP0005367_renal/urinary_system_phenotyp | 1.68668520 |
| 36 | MP0005671_abnormal_response_to | 1.63796819 |
| 37 | MP0002722_abnormal_immune_system | 1.61904344 |
| 38 | MP0001533_abnormal_skeleton_physiology | 1.59174360 |
| 39 | MP0004858_abnormal_nervous_system | 1.54888019 |
| 40 | MP0003329_amyloid_beta_deposits | 1.50844575 |
| 41 | MP0002909_abnormal_adrenal_gland | 1.49115960 |
| 42 | MP0001970_abnormal_pain_threshold | 1.47944394 |
| 43 | * MP0001800_abnormal_humoral_immune | 1.45428147 |
| 44 | * MP0002723_abnormal_immune_serum | 1.45114937 |
| 45 | MP0003866_abnormal_defecation | 1.44538819 |
| 46 | MP0002405_respiratory_system_inflammati | 1.44331496 |
| 47 | MP0002733_abnormal_thermal_nociception | 1.41608480 |
| 48 | MP0000685_abnormal_immune_system | 1.40797072 |
| 49 | MP0002006_tumorigenesis | 1.40600703 |
| 50 | MP0008004_abnormal_stomach_pH | 1.38887556 |
| 51 | MP0008770_decreased_survivor_rate | 1.37711470 |
| 52 | MP0009763_increased_sensitivity_to | 1.37147662 |
| 53 | MP0000343_altered_response_to | 1.36417779 |
| 54 | MP0004924_abnormal_behavior | 1.31926869 |
| 55 | MP0005386_behavior/neurological_phenoty | 1.31926869 |
| 56 | MP0002396_abnormal_hematopoietic_system | 1.28066356 |
| 57 | MP0009840_abnormal_foam_cell | 1.27390484 |
| 58 | MP0006035_abnormal_mitochondrial_morpho | 1.27063802 |
| 59 | MP0010307_abnormal_tumor_latency | 1.26970810 |
| 60 | MP0005084_abnormal_gallbladder_morpholo | 1.24752979 |
| 61 | * MP0000716_abnormal_immune_system | 1.23232897 |
| 62 | MP0005623_abnormal_meninges_morphology | 1.23067960 |
| 63 | * MP0002452_abnormal_antigen_presenting | 1.19652500 |
| 64 | MP0001986_abnormal_taste_sensitivity | 1.19235028 |
| 65 | * MP0002429_abnormal_blood_cell | 1.18870927 |
| 66 | MP0004859_abnormal_synaptic_plasticity | 1.17360644 |
| 67 | MP0001845_abnormal_inflammatory_respons | 1.16983569 |
| 68 | MP0005636_abnormal_mineral_homeostasis | 1.12541695 |
| 69 | MP0001664_abnormal_digestion | 1.12071770 |
| 70 | MP0005075_abnormal_melanosome_morpholog | 1.10601665 |
| 71 | MP0000689_abnormal_spleen_morphology | 1.09953269 |
| 72 | MP0001542_abnormal_bone_strength | 1.09844383 |
| 73 | MP0005670_abnormal_white_adipose | 1.09716777 |
| 74 | MP0005647_abnormal_sex_gland | 1.08541563 |
| 75 | MP0000703_abnormal_thymus_morphology | 1.07817973 |
| 76 | MP0000604_amyloidosis | 1.07437490 |
| 77 | MP0003252_abnormal_bile_duct | 1.05955531 |
| 78 | MP0000681_abnormal_thyroid_gland | 1.05587882 |
| 79 | MP0000569_abnormal_digit_pigmentation | 1.04923702 |
| 80 | MP0004084_abnormal_cardiac_muscle | 1.04882854 |
| 81 | MP0001188_hyperpigmentation | 1.04409841 |
| 82 | MP0002139_abnormal_hepatobiliary_system | 1.03674329 |
| 83 | MP0001756_abnormal_urination | 1.03590887 |
| 84 | MP0004510_myositis | 1.02900937 |
| 85 | MP0005360_urolithiasis | 1.01845292 |
| 86 | MP0005165_increased_susceptibility_to | 1.01643522 |
| 87 | MP0004085_abnormal_heartbeat | 1.01479631 |
| 88 | MP0001663_abnormal_digestive_system | 1.01353175 |
| 89 | MP0008874_decreased_physiological_sensi | 0.99955341 |
| 90 | MP0003186_abnormal_redox_activity | 0.97633624 |
| 91 | MP0005397_hematopoietic_system_phenotyp | 0.95877943 |
| 92 | MP0001545_abnormal_hematopoietic_system | 0.95877943 |
| 93 | MP0000372_irregular_coat_pigmentation | 0.95658853 |
| 94 | MP0009379_abnormal_foot_pigmentation | 0.94732738 |
| 95 | MP0004883_abnormal_blood_vessel | 0.94628260 |
| 96 | MP0003191_abnormal_cellular_cholesterol | 0.92738856 |
| 97 | MP0009333_abnormal_splenocyte_physiolog | 0.91457656 |
| 98 | MP0002837_dystrophic_cardiac_calcinosis | 0.91355352 |
| 99 | MP0003172_abnormal_lysosome_physiology | 0.91106335 |
| 100 | MP0001851_eye_inflammation | 0.90921700 |
| 101 | MP0004947_skin_inflammation | 0.89998571 |
| 102 | MP0001727_abnormal_embryo_implantation | 0.89451318 |
| 103 | MP0001765_abnormal_ion_homeostasis | 0.87880704 |
| 104 | MP0005390_skeleton_phenotype | 0.87852629 |
| 105 | * MP0008469_abnormal_protein_level | 0.85949093 |
| 106 | MP0005166_decreased_susceptibility_to | 0.85411902 |
| 107 | MP0009384_cardiac_valve_regurgitation | 0.84709987 |
| 108 | MP0001764_abnormal_homeostasis | 0.84595752 |
| 109 | MP0003806_abnormal_nucleotide_metabolis | 0.84316177 |
| 110 | MP0000858_altered_metastatic_potential | 0.82480259 |
| 111 | MP0001905_abnormal_dopamine_level | 0.81268476 |
| 112 | MP0001501_abnormal_sleep_pattern | 0.81196332 |
| 113 | MP0003656_abnormal_erythrocyte_physiolo | 0.80323995 |
| 114 | MP0002254_reproductive_system_inflammat | 0.79119020 |
| 115 | MP0003763_abnormal_thymus_physiology | 0.78364012 |
| 116 | MP0005334_abnormal_fat_pad | 0.78173165 |
| 117 | MP0000230_abnormal_systemic_arterial | 0.76827153 |
| 118 | MP0003183_abnormal_peptide_metabolism | 0.76268743 |
| 119 | MP0002998_abnormal_bone_remodeling | 0.75842575 |
| 120 | MP0004142_abnormal_muscle_tone | 0.75031702 |
| 121 | MP0002876_abnormal_thyroid_physiology | 0.74839085 |
| 122 | MP0002128_abnormal_blood_circulation | 0.74571377 |
| 123 | MP0008872_abnormal_physiological_respon | 0.74476942 |
| 124 | MP0010352_gastrointestinal_tract_polyps | 0.74389346 |
| 125 | MP0002972_abnormal_cardiac_muscle | 0.73882500 |
| 126 | MP0003075_altered_response_to | 0.72889737 |
| 127 | MP0008875_abnormal_xenobiotic_pharmacok | 0.72772240 |
| 128 | MP0009643_abnormal_urine_homeostasis | 0.72695490 |
| 129 | MP0001853_heart_inflammation | 0.72434757 |
| 130 | MP0009780_abnormal_chondrocyte_physiolo | 0.72027801 |
| 131 | MP0010155_abnormal_intestine_physiology | 0.71962904 |
| 132 | MP0003787_abnormal_imprinting | 0.71327624 |
| 133 | MP0005310_abnormal_salivary_gland | 0.71024431 |
| 134 | * MP0000249_abnormal_blood_vessel | 0.69297324 |
| 135 | MP0002132_abnormal_respiratory_system | 0.69256766 |
| 136 | MP0002019_abnormal_tumor_incidence | 0.69239884 |
| 137 | MP0005535_abnormal_body_temperature | 0.68424092 |
| 138 | MP0008961_abnormal_basal_metabolism | 0.66852475 |
| 139 | MP0003795_abnormal_bone_structure | 0.66432440 |
| 140 | MP0009764_decreased_sensitivity_to | 0.65521201 |
| 141 | MP0009278_abnormal_bone_marrow | 0.65389307 |
| 142 | MP0005645_abnormal_hypothalamus_physiol | 0.65131232 |
| 143 | MP0002009_preneoplasia | 0.62650491 |
| 144 | MP0005085_abnormal_gallbladder_physiolo | 0.62112621 |
| 145 | MP0002572_abnormal_emotion/affect_behav | 0.61915231 |
| 146 | MP0000462_abnormal_digestive_system | 0.60927182 |
| 147 | MP0006292_abnormal_olfactory_placode | 0.60546781 |
| 148 | MP0003828_pulmonary_edema | 0.59716423 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased mean platelet volume (HP:0011877) | 9.81366269 |
| 2 | Abnormal platelet volume (HP:0011876) | 9.52770536 |
| 3 | Purpura (HP:0000979) | 9.31062279 |
| 4 | Menorrhagia (HP:0000132) | 9.09929664 |
| 5 | Prolonged bleeding time (HP:0003010) | 9.06769606 |
| 6 | Abnormal platelet function (HP:0011869) | 8.26227533 |
| 7 | Impaired platelet aggregation (HP:0003540) | 8.26227533 |
| 8 | Gingival bleeding (HP:0000225) | 7.78758426 |
| 9 | Epistaxis (HP:0000421) | 4.82483144 |
| 10 | Papilledema (HP:0001085) | 4.65681281 |
| 11 | Aplastic anemia (HP:0001915) | 4.48889468 |
| 12 | Obstructive lung disease (HP:0006536) | 3.47290736 |
| 13 | Chronic obstructive pulmonary disease (HP:0006510) | 3.47290736 |
| 14 | Abnormality of alanine metabolism (HP:0010916) | 3.41007554 |
| 15 | Hyperalaninemia (HP:0003348) | 3.41007554 |
| 16 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.41007554 |
| 17 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.40719790 |
| 18 | Recurrent cutaneous fungal infections (HP:0011370) | 3.40719790 |
| 19 | Cellulitis (HP:0100658) | 3.29885795 |
| 20 | Exertional dyspnea (HP:0002875) | 3.22207104 |
| 21 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.20177891 |
| 22 | Bruising susceptibility (HP:0000978) | 3.19230719 |
| 23 | Abnormality of binocular vision (HP:0011514) | 3.11107388 |
| 24 | Diplopia (HP:0000651) | 3.11107388 |
| 25 | Chronic otitis media (HP:0000389) | 3.06551943 |
| 26 | Esophageal neoplasm (HP:0100751) | 2.99214301 |
| 27 | Neoplasm of head and neck (HP:0012288) | 2.99214301 |
| 28 | Recurrent bacterial skin infections (HP:0005406) | 2.95483091 |
| 29 | Stomatitis (HP:0010280) | 2.93395296 |
| 30 | Congenital, generalized hypertrichosis (HP:0004540) | 2.92470519 |
| 31 | Sex reversal (HP:0012245) | 2.91564052 |
| 32 | Abnormal sex determination (HP:0012244) | 2.91564052 |
| 33 | Lipid accumulation in hepatocytes (HP:0006561) | 2.82215841 |
| 34 | 3-Methylglutaconic aciduria (HP:0003535) | 2.80200196 |
| 35 | Hepatocellular necrosis (HP:0001404) | 2.79611820 |
| 36 | Poikilocytosis (HP:0004447) | 2.78243751 |
| 37 | Increased hepatocellular lipid droplets (HP:0006565) | 2.75354034 |
| 38 | Mitochondrial inheritance (HP:0001427) | 2.73601875 |
| 39 | Panhypogammaglobulinemia (HP:0003139) | 2.73230807 |
| 40 | Amyloidosis (HP:0011034) | 2.71980869 |
| 41 | Increased CSF lactate (HP:0002490) | 2.71529571 |
| 42 | Disinhibition (HP:0000734) | 2.69292152 |
| 43 | Abnormality of B cell number (HP:0010975) | 2.66922657 |
| 44 | Abolished electroretinogram (ERG) (HP:0000550) | 2.65858757 |
| 45 | Renal Fanconi syndrome (HP:0001994) | 2.64764045 |
| 46 | Hypoproteinemia (HP:0003075) | 2.64746611 |
| 47 | White forelock (HP:0002211) | 2.63189875 |
| 48 | Recurrent viral infections (HP:0004429) | 2.61829766 |
| 49 | Hemoptysis (HP:0002105) | 2.61483951 |
| 50 | Recurrent abscess formation (HP:0002722) | 2.59935345 |
| 51 | Pulmonary infiltrates (HP:0002113) | 2.59818958 |
| 52 | Meningitis (HP:0001287) | 2.59290153 |
| 53 | Short middle phalanx of the 5th finger (HP:0004220) | 2.57378691 |
| 54 | Autoimmune thrombocytopenia (HP:0001973) | 2.55718877 |
| 55 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.54614656 |
| 56 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.52523291 |
| 57 | Myositis (HP:0100614) | 2.50175793 |
| 58 | Acute hepatic failure (HP:0006554) | 2.49989945 |
| 59 | Acute necrotizing encephalopathy (HP:0006965) | 2.49200039 |
| 60 | Spontaneous abortion (HP:0005268) | 2.48472588 |
| 61 | Abnormality of secondary sexual hair (HP:0009888) | 2.47016176 |
| 62 | Abnormality of the axillary hair (HP:0100134) | 2.47016176 |
| 63 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.43329851 |
| 64 | Insomnia (HP:0100785) | 2.42894039 |
| 65 | Absent frontal sinuses (HP:0002688) | 2.41951008 |
| 66 | Mediastinal lymphadenopathy (HP:0100721) | 2.38526540 |
| 67 | Amaurosis fugax (HP:0100576) | 2.37577342 |
| 68 | Supranuclear gaze palsy (HP:0000605) | 2.35235537 |
| 69 | Gastrointestinal infarctions (HP:0005244) | 2.32176460 |
| 70 | Neurofibrillary tangles (HP:0002185) | 2.31719754 |
| 71 | Hepatic necrosis (HP:0002605) | 2.30424163 |
| 72 | Vasculitis (HP:0002633) | 2.30072323 |
| 73 | Patchy hypopigmentation of hair (HP:0011365) | 2.27857493 |
| 74 | Increased intramyocellular lipid droplets (HP:0012240) | 2.27703261 |
| 75 | Basal ganglia calcification (HP:0002135) | 2.27019747 |
| 76 | Tinnitus (HP:0000360) | 2.26433784 |
| 77 | Cerebral inclusion bodies (HP:0100314) | 2.26208437 |
| 78 | Gangrene (HP:0100758) | 2.22311282 |
| 79 | Increased muscle lipid content (HP:0009058) | 2.21806893 |
| 80 | Gastrointestinal stroma tumor (HP:0100723) | 2.21301843 |
| 81 | Hypertensive crisis (HP:0100735) | 2.17066947 |
| 82 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.16513510 |
| 83 | Progressive macrocephaly (HP:0004481) | 2.16010453 |
| 84 | Pruritus (HP:0000989) | 2.15106041 |
| 85 | Thrombophlebitis (HP:0004418) | 2.12435193 |
| 86 | Autoimmune hemolytic anemia (HP:0001890) | 2.11909338 |
| 87 | Abnormality of the basal ganglia (HP:0002134) | 2.11642365 |
| 88 | Agammaglobulinemia (HP:0004432) | 2.10628854 |
| 89 | Optic neuritis (HP:0100653) | 2.09824302 |
| 90 | Retrobulbar optic neuritis (HP:0100654) | 2.09824302 |
| 91 | Abnormality of the pleura (HP:0002103) | 2.09547646 |
| 92 | Abnormality of iron homeostasis (HP:0011031) | 2.08438356 |
| 93 | Acute encephalopathy (HP:0006846) | 2.07687719 |
| 94 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.07553670 |
| 95 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.07553670 |
| 96 | Abnormality of glycolipid metabolism (HP:0010969) | 2.07553670 |
| 97 | Loss of speech (HP:0002371) | 2.07282998 |
| 98 | Prolonged neonatal jaundice (HP:0006579) | 2.07276963 |
| 99 | Mucopolysacchariduria (HP:0008155) | 2.05107281 |
| 100 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.05107281 |
| 101 | Acute myeloid leukemia (HP:0004808) | 2.04854264 |
| 102 | IgM deficiency (HP:0002850) | 2.04337492 |
| 103 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.04252724 |
| 104 | B lymphocytopenia (HP:0010976) | 2.03443719 |
| 105 | Heterochromia iridis (HP:0001100) | 2.03129049 |
| 106 | Encephalitis (HP:0002383) | 2.02782621 |
| 107 | Urticaria (HP:0001025) | 2.02741661 |
| 108 | Recurrent fungal infections (HP:0002841) | 2.01079762 |
| 109 | Ureteral obstruction (HP:0006000) | 2.00701338 |
| 110 | Fatigue (HP:0012378) | 2.00523225 |
| 111 | Petechiae (HP:0000967) | 12.2972553 |
| 112 | Cerebral aneurysm (HP:0004944) | 1.99991073 |
| 113 | Type I transferrin isoform profile (HP:0003642) | 1.99824457 |
| 114 | Vertigo (HP:0002321) | 1.99675358 |
| 115 | Ureteral stenosis (HP:0000071) | 1.97236043 |
| 116 | Spastic paraparesis (HP:0002313) | 1.97121070 |
| 117 | Skin rash (HP:0000988) | 1.97101401 |
| 118 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 1.96996576 |
| 119 | Apathy (HP:0000741) | 1.96686300 |
| 120 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.95010765 |
| 121 | Polyneuropathy (HP:0001271) | 1.94939379 |
| 122 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.93741176 |
| 123 | Hyperacusis (HP:0010780) | 1.93589605 |
| 124 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.93178664 |
| 125 | Abnormal glycosylation (HP:0012345) | 1.93178664 |
| 126 | Deep venous thrombosis (HP:0002625) | 1.92447000 |
| 127 | Slender build (HP:0001533) | 1.87057457 |
| 128 | Hematochezia (HP:0002573) | 1.85935072 |
| 129 | Diminished motivation (HP:0000745) | 1.81992400 |
| 130 | Abnormality of oral frenula (HP:0000190) | 1.81661779 |
| 131 | Spontaneous hematomas (HP:0007420) | 1.78068178 |
| 132 | Germ cell neoplasia (HP:0100728) | 1.76854666 |
| 133 | Joint hemorrhage (HP:0005261) | 1.76340305 |
| 134 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.76028541 |
| 135 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.76028541 |
| 136 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.76028541 |
| 137 | Leukocytosis (HP:0001974) | 1.71178224 |
| 138 | Increased density of long bones (HP:0006392) | 1.67043802 |
| 139 | Inflammation of the large intestine (HP:0002037) | 1.66117916 |
| 140 | Renal salt wasting (HP:0000127) | 1.60299506 |
| 141 | Recurrent skin infections (HP:0001581) | 1.59964698 |
| 142 | Gastrointestinal inflammation (HP:0004386) | 1.58916459 |
| 143 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.58565496 |
| 144 | Abnormality of the prostate (HP:0008775) | 1.57588335 |
| 145 | Increased cerebral lipofuscin (HP:0011813) | 1.55963404 |
| 146 | Disproportionate tall stature (HP:0001519) | 1.54372754 |
| 147 | Polycythemia (HP:0001901) | 1.54313923 |
| 148 | Xanthomatosis (HP:0000991) | 1.53068902 |
| 149 | Hyperaldosteronism (HP:0000859) | 1.52225082 |
| 150 | Nasal polyposis (HP:0100582) | 1.51565666 |
| 151 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.50018684 |
| 152 | Global brain atrophy (HP:0002283) | 1.47584872 |
| 153 | Abnormality of lateral ventricle (HP:0030047) | 1.44580755 |
| 154 | Gonadal dysgenesis (HP:0000133) | 1.43822557 |
| 155 | Abnormality of the lumbar spine (HP:0100712) | 1.40053924 |
| 156 | Acrocyanosis (HP:0001063) | 1.39640691 |
| 157 | Large hands (HP:0001176) | 1.39213069 |
| 158 | Abnormality of eosinophils (HP:0001879) | 1.38280154 |
| 159 | Dysostosis multiplex (HP:0000943) | 1.37816830 |
| 160 | Neoplasm of the rectum (HP:0100743) | 1.37773756 |
| 161 | Severe short stature (HP:0003510) | 1.37168103 |
| 162 | Hemiplegia (HP:0002301) | 1.36940270 |
| 163 | Vacuolated lymphocytes (HP:0001922) | 1.36652195 |
| 164 | Chest pain (HP:0100749) | 1.35316991 |
| 165 | Colitis (HP:0002583) | 1.35048829 |
| 166 | Lymphedema (HP:0001004) | 1.35010171 |
| 167 | Ankyloglossia (HP:0010296) | 1.33955413 |
| 168 | Abnormality of the nasal mucosa (HP:0000433) | 1.29973755 |
| 169 | Arterial thrombosis (HP:0004420) | 1.29569984 |
| 170 | Fibroma (HP:0010614) | 1.28710833 |
| 171 | Adrenal overactivity (HP:0002717) | 1.28604938 |
| 172 | Cervical subluxation (HP:0003308) | 1.27398621 |
| 173 | Amyotrophic lateral sclerosis (HP:0007354) | 1.26722648 |
| 174 | Thoracolumbar scoliosis (HP:0002944) | 1.25783941 |
| 175 | Sudden cardiac death (HP:0001645) | 1.24800802 |
| 176 | Thrombocytosis (HP:0001894) | 1.23683294 |
| 177 | Abnormality of the Achilles tendon (HP:0005109) | 1.23215258 |
| 178 | Fibrous tissue neoplasm (HP:0012316) | 1.22858636 |
| 179 | Pulmonary embolism (HP:0002204) | 1.21649378 |
| 180 | Neuronal loss in central nervous system (HP:0002529) | 1.19902735 |
| 181 | Myelodysplasia (HP:0002863) | 1.19596771 |
| 182 | Neoplasm of the small intestine (HP:0100833) | 1.18731972 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KIT | 6.77124718 |
| 2 | BMPR2 | 4.56058243 |
| 3 | CDK19 | 4.51770968 |
| 4 | MATK | 4.21553890 |
| 5 | MAP4K2 | 4.21393125 |
| 6 | RIPK4 | 3.52562625 |
| 7 | EEF2K | 3.50903803 |
| 8 | FES | 3.33143471 |
| 9 | MAP4K1 | 3.11456780 |
| 10 | TLK1 | 3.03797739 |
| 11 | TXK | 2.77037323 |
| 12 | CDK6 | 2.54479349 |
| 13 | BLK | 2.44435018 |
| 14 | CSF1R | 2.42244782 |
| 15 | PINK1 | 2.41518861 |
| 16 | TRIB3 | 2.39715149 |
| 17 | NTRK2 | 2.25943102 |
| 18 | ERBB3 | 2.13102869 |
| 19 | GRK6 | 2.12912607 |
| 20 | PIM2 | 1.81579636 |
| 21 | ZAP70 | 1.74848369 |
| 22 | SYK | 1.73585246 |
| 23 | FRK | 1.70502110 |
| 24 | MAPKAPK5 | 1.70017685 |
| 25 | TYK2 | 1.69864019 |
| 26 | MYLK | 1.66487879 |
| 27 | TGFBR2 | 1.53065613 |
| 28 | OXSR1 | 1.52444596 |
| 29 | PKN2 | 1.51359415 |
| 30 | FGFR2 | 1.50712061 |
| 31 | MAPK15 | 1.50213135 |
| 32 | CCNB1 | 1.47302157 |
| 33 | MAPKAPK3 | 1.44127852 |
| 34 | IKBKB | 1.37866488 |
| 35 | CSNK1G3 | 1.35605020 |
| 36 | ITK | 1.34952504 |
| 37 | TAOK3 | 1.34657351 |
| 38 | JAK2 | 1.33893154 |
| 39 | FGFR4 | 1.33633724 |
| 40 | SIK2 | 1.30111410 |
| 41 | PTK6 | 1.27650690 |
| 42 | MAPKAPK2 | 1.24444393 |
| 43 | BMX | 1.23566661 |
| 44 | LYN | 1.23078363 |
| 45 | PRKACG | 1.21504970 |
| 46 | EIF2AK3 | 1.20474978 |
| 47 | NEK9 | 1.17094610 |
| 48 | ALK | 1.15326487 |
| 49 | CAMK1G | 1.09569040 |
| 50 | LRRK2 | 1.08727165 |
| 51 | CSNK1G2 | 1.03736750 |
| 52 | FLT3 | 1.01705349 |
| 53 | RPS6KA5 | 1.01558947 |
| 54 | TYRO3 | 0.98670423 |
| 55 | MARK3 | 0.98402386 |
| 56 | BTK | 0.98220588 |
| 57 | SCYL2 | 0.96836290 |
| 58 | ABL1 | 0.93466374 |
| 59 | HIPK2 | 0.93430067 |
| 60 | PRKACB | 0.91076264 |
| 61 | CAMKK2 | 0.90671937 |
| 62 | TRPM7 | 0.88847397 |
| 63 | CAMK1D | 0.88364750 |
| 64 | RPS6KB2 | 0.87348803 |
| 65 | SIK1 | 0.83767787 |
| 66 | DAPK2 | 0.83464456 |
| 67 | CAMKK1 | 0.81618650 |
| 68 | STK10 | 0.81475863 |
| 69 | TEC | 0.80606497 |
| 70 | ADRBK2 | 0.78975291 |
| 71 | RPS6KA4 | 0.78312105 |
| 72 | CSNK1G1 | 0.78277656 |
| 73 | NUAK1 | 0.75185296 |
| 74 | HCK | 0.75178271 |
| 75 | PKN1 | 0.74099790 |
| 76 | IGF1R | 0.71821176 |
| 77 | INSRR | 0.71678827 |
| 78 | IRAK4 | 0.66818848 |
| 79 | EGFR | 0.65172316 |
| 80 | PRKCD | 0.64435861 |
| 81 | BCKDK | 0.62581596 |
| 82 | PIM1 | 0.62077222 |
| 83 | EPHB1 | 0.61457877 |
| 84 | RPS6KA2 | 0.60397256 |
| 85 | LCK | 0.60060729 |
| 86 | GRK7 | 0.59675443 |
| 87 | FGFR3 | 0.59142599 |
| 88 | GRK1 | 0.58613062 |
| 89 | PAK2 | 0.57527292 |
| 90 | JAK1 | 0.56855233 |
| 91 | MKNK1 | 0.55818566 |
| 92 | NME2 | 0.55626441 |
| 93 | AURKB | 0.55151944 |
| 94 | NME1 | 0.54959094 |
| 95 | MAP2K1 | 0.54469711 |
| 96 | UHMK1 | 0.54250702 |
| 97 | PRKCQ | 0.53368056 |
| 98 | PDGFRA | 0.52946871 |
| 99 | MAP3K7 | 0.51408517 |
| 100 | ABL2 | 0.51330141 |
| 101 | SRC | 0.49668135 |
| 102 | RET | 0.49460410 |
| 103 | OBSCN | 0.48865075 |
| 104 | MAP3K11 | 0.48412581 |
| 105 | PRKG1 | 0.45470740 |
| 106 | FGR | 0.45317440 |
| 107 | MAP3K14 | 0.44793705 |
| 108 | PRKG2 | 0.44310534 |
| 109 | MAP3K12 | 0.44205922 |
| 110 | JAK3 | 0.43660820 |
| 111 | MINK1 | 0.43411414 |
| 112 | MAP3K6 | 0.41861298 |
| 113 | TNK2 | 0.41769827 |
| 114 | FYN | 0.41264347 |
| 115 | KSR2 | 0.41059914 |
| 116 | MAPK11 | 0.40869295 |
| 117 | PIK3CG | 0.40545829 |
| 118 | PRKCE | 0.40381068 |
| 119 | CDK4 | 0.40178150 |
| 120 | MAP3K1 | 0.39624785 |
| 121 | DYRK1B | 0.39582440 |
| 122 | ERN1 | 0.38882871 |
| 123 | PTK2B | 0.38594796 |
| 124 | KDR | 0.38333688 |
| 125 | PRKCB | 0.37472340 |
| 126 | MAPK4 | 0.36631696 |
| 127 | MAP2K6 | 0.35856106 |
| 128 | IKBKE | 0.35520970 |
| 129 | PDGFRB | 0.35494282 |
| 130 | CSNK2A1 | 0.35308581 |
| 131 | CHUK | 0.35245422 |
| 132 | PRKCA | 0.34992009 |
| 133 | TBK1 | 0.34922940 |
| 134 | TESK2 | 0.33478701 |
| 135 | PRKD1 | 0.33284460 |
| 136 | DAPK1 | 0.32731326 |
| 137 | CSNK2A2 | 0.32686067 |
| 138 | RPS6KA3 | 0.32527667 |
| 139 | DYRK3 | 0.32243309 |
| 140 | ADRBK1 | 0.32188938 |
| 141 | ARAF | 0.31753821 |
| 142 | ZAK | 0.31428274 |
| 143 | MAP3K2 | 0.30601668 |
| 144 | CSNK1A1 | 0.29689606 |
| 145 | ILK | 0.29196128 |
| 146 | MAP2K3 | 0.28681871 |
| 147 | PRKACA | 0.27578156 |
| 148 | TAOK2 | 0.27098387 |
| 149 | MAP3K5 | 0.26350883 |
| 150 | CDC7 | 0.26021638 |
| 151 | CSK | 0.25898209 |
| 152 | DAPK3 | 0.25220593 |
| 153 | PAK4 | 0.24748622 |
| 154 | CDK5 | 0.23898215 |
| 155 | TAOK1 | 0.23580480 |
| 156 | PDK1 | 0.22525622 |
| 157 | MAPK1 | 0.22466382 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 4.89210094 |
| 2 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.64105022 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.58482591 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 4.27651606 |
| 5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.95345264 |
| 6 | * Asthma_Homo sapiens_hsa05310 | 3.54748007 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.32360761 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.11450816 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.63456077 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.62436772 |
| 11 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.53559605 |
| 12 | Renin-angiotensin system_Homo sapiens_hsa04614 | 13.1013921 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.91712031 |
| 14 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.89210961 |
| 15 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.84597428 |
| 16 | * Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.79950475 |
| 17 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.72256530 |
| 18 | Tuberculosis_Homo sapiens_hsa05152 | 1.68134292 |
| 19 | Platelet activation_Homo sapiens_hsa04611 | 1.65791440 |
| 20 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.63416192 |
| 21 | Parkinsons disease_Homo sapiens_hsa05012 | 1.58509525 |
| 22 | Ribosome_Homo sapiens_hsa03010 | 1.54988769 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.54294927 |
| 24 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.41103276 |
| 25 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.38815814 |
| 26 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.32832552 |
| 27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.31596825 |
| 28 | Cocaine addiction_Homo sapiens_hsa05030 | 1.30440374 |
| 29 | Influenza A_Homo sapiens_hsa05164 | 1.09794670 |
| 30 | Proteasome_Homo sapiens_hsa03050 | 1.09434904 |
| 31 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.08377111 |
| 32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.06994977 |
| 33 | Phagosome_Homo sapiens_hsa04145 | 1.05509019 |
| 34 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.05500404 |
| 35 | Legionellosis_Homo sapiens_hsa05134 | 1.05121472 |
| 36 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.02205474 |
| 37 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.01733445 |
| 38 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.00818881 |
| 39 | Alzheimers disease_Homo sapiens_hsa05010 | 0.95794833 |
| 40 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.92040869 |
| 41 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.90462630 |
| 42 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.87830725 |
| 43 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.83477503 |
| 44 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.82803833 |
| 45 | Huntingtons disease_Homo sapiens_hsa05016 | 0.79609850 |
| 46 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.79499617 |
| 47 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.78449144 |
| 48 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.76515468 |
| 49 | Prion diseases_Homo sapiens_hsa05020 | 0.74378541 |
| 50 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.74349323 |
| 51 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.72496387 |
| 52 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.72048880 |
| 53 | Salmonella infection_Homo sapiens_hsa05132 | 0.71638406 |
| 54 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.71540399 |
| 55 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.71268855 |
| 56 | Malaria_Homo sapiens_hsa05144 | 0.69777687 |
| 57 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.68325051 |
| 58 | Pertussis_Homo sapiens_hsa05133 | 0.68160086 |
| 59 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.65047039 |
| 60 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.63832394 |
| 61 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.63245813 |
| 62 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62169119 |
| 63 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.61411212 |
| 64 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.59748663 |
| 65 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.58329620 |
| 66 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.56855881 |
| 67 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.54725158 |
| 68 | Homologous recombination_Homo sapiens_hsa03440 | 0.54203256 |
| 69 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.53558800 |
| 70 | Lysosome_Homo sapiens_hsa04142 | 0.53436470 |
| 71 | Leishmaniasis_Homo sapiens_hsa05140 | 0.52540987 |
| 72 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.52496231 |
| 73 | Long-term potentiation_Homo sapiens_hsa04720 | 0.51356138 |
| 74 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.50123807 |
| 75 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.49923515 |
| 76 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.49906051 |
| 77 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.48992213 |
| 78 | Histidine metabolism_Homo sapiens_hsa00340 | 0.48817167 |
| 79 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.48394105 |
| 80 | Salivary secretion_Homo sapiens_hsa04970 | 0.48341329 |
| 81 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.47311075 |
| 82 | Glioma_Homo sapiens_hsa05214 | 0.46620875 |
| 83 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.45628491 |
| 84 | Hepatitis B_Homo sapiens_hsa05161 | 0.45149596 |
| 85 | Phototransduction_Homo sapiens_hsa04744 | 0.43781792 |
| 86 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.43024363 |
| 87 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.42537446 |
| 88 | RNA degradation_Homo sapiens_hsa03018 | 0.40782171 |
| 89 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.39187674 |
| 90 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.37705374 |
| 91 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.37628730 |
| 92 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.37564344 |
| 93 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.37315244 |
| 94 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.37313259 |
| 95 | Protein export_Homo sapiens_hsa03060 | 0.36994589 |
| 96 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.36985234 |
| 97 | Apoptosis_Homo sapiens_hsa04210 | 0.35920882 |
| 98 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.35038396 |
| 99 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.34813661 |
| 100 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.34499688 |
| 101 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34304441 |
| 102 | Colorectal cancer_Homo sapiens_hsa05210 | 0.34015358 |
| 103 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.33698239 |
| 104 | Focal adhesion_Homo sapiens_hsa04510 | 0.32088696 |
| 105 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.31588823 |
| 106 | Other glycan degradation_Homo sapiens_hsa00511 | 0.31352880 |
| 107 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.30870836 |
| 108 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.30621173 |
| 109 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.29589167 |
| 110 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.29350376 |
| 111 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.29331991 |
| 112 | Amoebiasis_Homo sapiens_hsa05146 | 0.29229715 |
| 113 | Viral myocarditis_Homo sapiens_hsa05416 | 0.29134379 |
| 114 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.28878849 |
| 115 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.28331575 |
| 116 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.27869726 |
| 117 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.27699674 |
| 118 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.27151632 |
| 119 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.26808400 |
| 120 | Circadian entrainment_Homo sapiens_hsa04713 | 0.26576605 |
| 121 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.25535905 |
| 122 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.25394560 |
| 123 | Bile secretion_Homo sapiens_hsa04976 | 0.25359207 |
| 124 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.25052088 |
| 125 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.25047202 |
| 126 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.24825919 |
| 127 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.24669126 |
| 128 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.24543425 |
| 129 | Peroxisome_Homo sapiens_hsa04146 | 0.24076397 |
| 130 | Gap junction_Homo sapiens_hsa04540 | 0.23972621 |
| 131 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.23456166 |
| 132 | Olfactory transduction_Homo sapiens_hsa04740 | 0.23171183 |
| 133 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.22375195 |
| 134 | Shigellosis_Homo sapiens_hsa05131 | 0.21525314 |
| 135 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.21465493 |
| 136 | Morphine addiction_Homo sapiens_hsa05032 | 0.21368156 |
| 137 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.21271476 |
| 138 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.21164347 |
| 139 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.21122884 |
| 140 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.21070963 |
| 141 | Renin secretion_Homo sapiens_hsa04924 | 0.21035565 |
| 142 | Insulin resistance_Homo sapiens_hsa04931 | 0.20460685 |
| 143 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.19426845 |
| 144 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.19151048 |
| 145 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.18826108 |
| 146 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.18757255 |
| 147 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.18539587 |
| 148 | Endocytosis_Homo sapiens_hsa04144 | 0.18504649 |
| 149 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.18349083 |
| 150 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.18338803 |
| 151 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.18256620 |
| 152 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.17750878 |
| 153 | Purine metabolism_Homo sapiens_hsa00230 | 0.17034015 |
| 154 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.16071570 |
| 155 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.15582458 |
| 156 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.15535485 |
| 157 | Pathways in cancer_Homo sapiens_hsa05200 | 0.15429033 |
| 158 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.13276113 |
| 159 | Base excision repair_Homo sapiens_hsa03410 | 0.13242990 |
| 160 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.13042592 |
| 161 | Taste transduction_Homo sapiens_hsa04742 | 0.12338063 |
| 162 | Measles_Homo sapiens_hsa05162 | 0.12125583 |
| 163 | HTLV-I infection_Homo sapiens_hsa05166 | 0.11577170 |
| 164 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.10885162 |
| 165 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.09903079 |
| 166 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.09460710 |
| 167 | Spliceosome_Homo sapiens_hsa03040 | 0.09119291 |
| 168 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.08566441 |
| 169 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.08413387 |
| 170 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.06812755 |
| 171 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.06541559 |
| 172 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.05286780 |
| 173 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.04257381 |
| 174 | Metabolic pathways_Homo sapiens_hsa01100 | 0.03943549 |
| 175 | Retinol metabolism_Homo sapiens_hsa00830 | 0.02065527 |
| 176 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.01614691 |
| 177 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.01249026 |
| 178 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.00371025 |

